Luye Pharma Files New Drug Application for Lurbinectedin in Hong Kong

For the Treatment of Metastatic Small Cell Lung Cancer

Luye Pharma and Biostar Enter into a Partnership for Marketing Innovative Anticancer Drug ...

Marketing Authorization Application for Luye Pharma's Innovative Anticancer Formulation Go...

Luye Pharma Releases Top-Line Results from a Phase II Clinical Trial of Its New Antidepres...

Showing a comprehensive antidepressant efficacy and a good safety profile

Luye Pharma Grants Gensci Exclusive Commercialization Rights of Rivastigmine Transdermal P...

Luye Pharma’s Rykindo® (Risperidone Microspheres for Injection (II)) Included in the 2021...

China’s first domestically created innovative injection of microspheres will benefit more patients